{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T19:10:18Z","timestamp":1738523418490,"version":"3.35.0"},"reference-count":17,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sexually Transmitted Infections"],"published-print":{"date-parts":[[1994,12,1]]},"DOI":"10.1136\/sti.70.6.389","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T21:44:35Z","timestamp":1226526275000},"page":"389-393","source":"Crossref","is-referenced-by-count":1,"title":["A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata."],"prefix":"10.1136","volume":"70","author":[{"given":"D K","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R D","family":"Maw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W W","family":"Dinsmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G D","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R S","family":"Pattman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P G","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P M","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Nayagam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/095646249200300609","article-title":"Treatment of anogenital warts in genitourinary clinics in England and Wales","volume":"8","author":"Wardropper, A.; Woolley, P.","year":"1992","unstructured":"Wardropper A, Woolley P. Treatment of anogenital warts in genitourinary clinics in England and Wales. Int Jf STD Aids 1992;8:439-41.","journal-title":"Int Jf STD Aids"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0002-9378(90)90383-I","article-title":"Intralesional interferon alfa-2b for the treatment of genital warts","volume":"162","author":"Welander, C.E.; Homesley, H.D.; Smiles, K.A.; Peets, E.A.","year":"1990","unstructured":"Welander CE, Homesley HD, Smiles KA, Peets EA. Intralesional interferon alfa-2b for the treatment of genital warts. AmJ Obstet Gynecol 1990;162:348-54.","journal-title":"AmJ Obstet Gynecol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.1988.03720040025021","article-title":"Natural interferon alfa for treatment of condylomata acuminata","volume":"259","author":"Friedman-Kien, A.E.; Eron, L.J.; Canant, M.","year":"1988","unstructured":"Friedman-Kien AE, Eron LJ, Canant M, et al. Natural interferon alfa for treatment of condylomata acuminata. JAMA 1988;259:533-8.","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7326\/0003-4819-108-5-675","article-title":"Treatment of condyloma acuminatum with three different interferons administered intralesionally","volume":"108","author":"Reichman, R.C.; Oakes, D.; Bonnez, W.","year":"1988","unstructured":"Reichman RC, Oakes D, Bonnez W, et al. Treatment of condyloma acuminatum with three different interferons administered intralesionally. Ann Intern Med 1988;108: 675-9.","journal-title":"Ann Intern Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM198610233151704","article-title":"Interferon therapy for condyloma acuminata","volume":"315","author":"L4, Eron; F, Judson; S, Tucker","year":"1986","unstructured":"Eron L4, Judson F, Tucker S, et al. Interferon therapy for condyloma acuminata. N Engl Jf Med 1986;315: 1059-64.","journal-title":"N Engl Jf Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00006250-198605000-00008","article-title":"Efficacy of human lymphoblastoid interferon in the therapy of resistant condyloma acuminata","volume":"67","author":"Gall, S.A.; Hughes, C.E.; Mounts, P.","year":"1986","unstructured":"Gall SA, Hughes CE, Mounts P, et al. Efficacy of human lymphoblastoid interferon in the therapy of resistant condyloma acuminata. Obstet Gynecol 1986;67:643-51.","journal-title":"Obstet Gynecol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9343(88)80339-5","article-title":"Tolerance and efficacy of recombinant human interferon gamma in the treatment of refractory genital warts","volume":"85","author":"Kirby, P.K.; Kiviat, N.; Beckman, A.","year":"1988","unstructured":"Kirby PK, Kiviat N, Beckman A, et al. Tolerance and efficacy of recombinant human interferon gamma in the treatment of refractory genital warts. Am 7 Med 1988; 85:183-8.","journal-title":"Am 7 Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/infdis\/162.6.1270","article-title":"Treatment of condyloma acuminata with three different interferonalpha preparations administered parenterally: a doubleblind, placebo-controlled trial","volume":"162","author":"Reichman, R.C.; Oakes, D.; Bonnez, W.","year":"1990","unstructured":"Reichman RC, Oakes D, Bonnez W, et al. Treatment of condyloma acuminata with three different interferonalpha preparations administered parenterally: a doubleblind, placebo-controlled trial. _J Infect Dis 1990;162: 1270-6.","journal-title":"_J Infect Dis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/095646249200300509","article-title":"Clinical study with recombinant interferon gamma versus interferon alpha2c in patients with condylomata acuminata","volume":"3","author":"Reichel, R.P.; Fitz, R.; Neumann, R.","year":"1992","unstructured":"Reichel RP, Fitz R, Neumann R, et al. Clinical study with recombinant interferon gamma versus interferon alpha2c in patients with condylomata acuminata. Int JSTD Aids 1992;3:350-4.","journal-title":"Int JSTD Aids"},{"key":"ref_10","first-page":"124","article-title":"Treatment of anogenital wartscomparison of trichloracetic acid and podophyllin versus podophyllin alone","volume":"59","author":"Gabriel, G.; Thin, R.N.T.","year":"1983","unstructured":"Gabriel G, Thin RNT. Treatment of anogenital wartscomparison of trichloracetic acid and podophyllin versus podophyllin alone. BrJ Venereal Dis 1983;59:124-6.","journal-title":"BrJ Venereal Dis"},{"key":"ref_11","first-page":"208","article-title":"Podophyllin 10% and 25% in the treatment of anogenital warts","volume":"57","author":"Simmons, P.D.","year":"1981","unstructured":"Simmons PD. Podophyllin 10% and 25% in the treatment of anogenital warts. BrJ Venereal Dis 1981;57:208-9.","journal-title":"BrJ Venereal Dis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(87)91823-X","article-title":"Comparison of podophyllotoxin and podophyllin in treatment of genital warts","volume":"ii:","author":"Lassus, A.","year":"1987","unstructured":"Lassus A. Comparison of podophyllotoxin and podophyllin in treatment of genital warts. Lancet 1987;ii: 512-3.","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/infdis\/162.1.52","article-title":"A randomized trial of combination therapy with intralesional interferon alpha-2b and podophyllin versus podophyllin alone for therapy of anogenital warts","volume":"162","author":"true","year":"1990","unstructured":"Douglas JM, Eron 14, Judson FN, et al. A randomized trial of combination therapy with intralesional interferon alpha-2b and podophyllin versus podophyllin alone for therapy of anogenital warts. _Infect Dis 1990;162:52-9.","journal-title":"_Infect Dis"},{"key":"ref_14","first-page":"99","article-title":"Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebocontrolled study","volume":"67","author":"Petersen, C.S.; Bjerring, P.; Larsen, J.","year":"1991","unstructured":"Petersen CS, Bjerring P, Larsen J, et al. Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebocontrolled study. Genitourin Med 1991;67:99-102.","journal-title":"Genitourin Med"},{"key":"ref_15","first-page":"815","article-title":"Superficial laser vulvectomy-enhanced by adjuvant systemic interferon. AmJ7 Obstet Gynecol","volume":"166","author":"Reid, R.; Greenberg, M.D.; Pizzuh, D.J.","year":"1992","unstructured":"Reid R, Greenberg MD, Pizzuh DJ, et al. Superficial laser vulvectomy-enhanced by adjuvant systemic interferon. AmJ7 Obstet Gynecol 1992;166:815-20."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2340\/0001555572383386","article-title":"Adjuvant treatment of recalcitrant genitoanal warts with systemic recombinant interferonalpha-2c","volume":"72","author":"Hopfl, R.M.; Sandbichler, M.; Zelger, B.W.H.; Conrad, F.G.; Fritsch, P.O.","year":"1992","unstructured":"Hopfl RM, Sandbichler M, Zelger BWH, Conrad FG, Fritsch PO. Adjuvant treatment of recalcitrant genitoanal warts with systemic recombinant interferonalpha-2c. Acta Dermato Venereol. 1992;72:383-.","journal-title":"Acta Dermato Venereol"},{"key":"ref_17","first-page":"297","article-title":"Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study","volume":"67","author":"Handley, J.M.; Homer, T.; Maw, R.D.; Lawther, H.; Dinsmore, W.W.","year":"1991","unstructured":"Handley JM, Homer T, Maw RD, Lawther H, Dinsmore WW. Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study. Genitourin Med 1991;67: 297-302.","journal-title":"Genitourin Med"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T18:28:42Z","timestamp":1738520922000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sti.70.6.389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,12,1]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1994,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/sti.70.6.389","relation":{},"ISSN":["1368-4973"],"issn-type":[{"type":"print","value":"1368-4973"}],"subject":[],"published":{"date-parts":[[1994,12,1]]}}}